BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.66% |
| 2 | Healthcare | 6.66% |
| 3 | Financials | 5.71% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Communication Services | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
CorMedix
CRMD
$639M
| $28.3K | ﹤0.01% |
7,881
+4,232
| +116% | +$23.9K |
|
3652
Tilly's
TLYS
$122M
| $28.2K | ﹤0.01% |
6,831
+1,480
| +28% | +$10.9K |
|
3653
Superior Group of Companies
SGC
$210M
| $28.1K | ﹤0.01% |
3,326
+968
| +41% | +$11.3K |
|
3654
Evolus
EOLS
$530M
| $28.1K | ﹤0.01% |
6,776
+4,583
| +209% | +$38.8K |
|
3655
IDT Corp
IDT
$1.67B
| $28.1K | ﹤0.01% |
5,186
+2,374
| +84% | +$17K |
|
|
TCRR
3656
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $28K | ﹤0.01% |
3,617
+904
| +33% | +$11.1K |
|
3657
Intrepid Potash
IPI
$484M
| $27.8K | ﹤0.01% |
3,472
+880
| +34% | +$16.4K |
|
3658
Union Bankshares
UNB
$122M
| $27.7K | ﹤0.01% |
1,233
+361
| +41% | +$11K |
|
|
REV
3659
DELISTED
Revlon, Inc.
REV
| $27.7K | ﹤0.01% |
2,537
+1,229
| +94% | +$22.5K |
|
3660
Provident Financial
PROV
$113M
| $27.5K | ﹤0.01% |
1,806
+405
| +29% | +$7.98K |
|
|
XXII
3661
22nd Century Group
XXII
$1.42M
| – | – |
0
| – | – |
|
|
PEI
3662
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $27.3K | ﹤0.01% |
1,999
+624
| +45% | +$30.2K |
|
|
ZYNE
3663
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $27.2K | ﹤0.01% |
7,095
+3,793
| +115% | +$17.6K |
|
|
UBFO
3664
DELISTED
United Security Bancshares
UBFO
| $27.2K | ﹤0.01% |
4,244
+913
| +27% | +$8.21K |
|
3665
Savara
SVRA
$1.08B
| $27K | ﹤0.01% |
12,746
+8,059
| +172% | +$22.1K |
|
|
RYZ
3666
Ryerson Holding Corp
RYZ
$1.5B
| $27K | ﹤0.01% |
5,075
+2,160
| +74% | +$19.1K |
|
3667
Funko
FNKO
$335M
| $27K | ﹤0.01% |
6,761
+3,129
| +86% | +$31.9K |
|
3668
Ponce Financial Group
PDLB
$501M
| $26.9K | ﹤0.01% |
3,656
+802
| +28% | +$7.68K |
|
|
HOOK
3669
DELISTED
HOOKIPA Pharma
HOOK
| $26.9K | ﹤0.01% |
326
+174
| +114% | +$19.1K |
|
|
LJPC
3670
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $26.8K | ﹤0.01% |
6,372
+3,378
| +113% | +$21.3K |
|
3671
Lexicon Pharmaceuticals
LXRX
$1.04B
| $26.8K | ﹤0.01% |
13,720
+7,992
| +140% | +$23.8K |
|
3672
SEACOR Marine Holdings
SMHI
$262M
| $26.6K | ﹤0.01% |
6,084
+1,375
| +29% | +$12.1K |
|
3673
Mercer International
MERC
$33.8M
| $26.5K | ﹤0.01% |
3,667
-798
| -18% | -$8K |
|
3674
Quad
QUAD
$506M
| $26.5K | ﹤0.01% |
10,499
-4,987
| -32% | -$22K |
|
3675
Senseonics Holdings Inc
SENS
$409M
| $26.4K | ﹤0.01% |
2,080
+1,177
| +130% | +$23.7K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.